Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 evaluation of silymarin for treatment of patients with COVID-19
PACTR202012898601759Phase 2Not yet recruiting
- Sponsor
- Africa Centre of Excellence in Phytomedicine Research and Development
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of silymarin and chloroquine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Africa Centre of Excellence in Phytomedicine Research and Development. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
silymarinchloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202012898601759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202012898601759.